<?xml version="1.0" encoding="iso-8859-1" ?>
<PASBIO>
    <framesest>
        <predicate lemma="splice">
            <roleset id="splice.01" name="" wordnet="3">
                <roles>
                    <role n="0" descr="gene or RNA&#x09;&#x09;&#x09;&#x09;&#x09;&#x09;&#x0A;" />
                    <role n="1" descr="specific component in gene/RNA to get spliced&#x09;&#x09;&#x09;// eg. extron, intron //&#x0A;" />
                    <role n="2" descr="gene product&#x09;&#x09;&#x09;&#x09;&#x09;&#x09;&#x09;// mRNA //&#x0A;" />
                    <role n="3" descr="location referring to organelle, cell or tissue&#x0A;" />
                </roles>
                <example src="EGRAM" no="0">
                    <text>A0 can be made and spliced into transformed cells and nuclear extracts.</text>
                    <arg n="3">transformed cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="1">
                    <text>A0 has also been spliced (four transcriptional units) that are observed to be spalmated but contain no obvious open reading framework.</text>
                </example>
                <example src="EGRAM" no="2">
                    <text>A0 has also been spliced (four transcriptional units) that can be spalmated but do not contain any obvious open reading framework.</text>
                </example>
                <example src="EGRAM" no="3">
                    <text>A0 is observed to be made (a caspasa-2 minigen construction) that is spliced in transfected cells and nuclear extracts.</text>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="4">
                    <text>A0 is observed to be made (a caspasa-2) minigen construction that is alternatively spliced to transfected cells and nuclear extracts.</text>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="5">
                    <text>A0 was made (a caspasa-2 minigen construction) that was spliced to transcent cells and nuclear extracts.</text>
                    <arg n="3">transcent cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="6">
                    <text>A0 was made and can be spliced into transformed cells and nuclear extracts.</text>
                    <arg n="3">transformed cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="7">
                    <text>A0 was made to be spliced into transformed cells and nuclear extracts.</text>
                    <arg n="3">transformed cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="8">
                    <text>An additional observation with substrates 3? was that the efficiency of the ligation of the bimolecular exon 3 decreased step by step with each mutation that moved the 5?-plus AG 6 nt down, so that RNA 3I is able to splice only 20% as efficiently as 3F (Fig.1 C Left).</text>
                    <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="9">
                    <text>An additional observation with tandem 3 repetition substrates was that the efficiency of bimolecular exon 3 ligation decreased progressively with each mutation that moved the 5?-greater AG 6 nt downwards, so that RNA 3I can splice only 20% efficiently as RNA 3F (Fig.1 C Left).</text>
                    <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="10">
                    <text>An additional observation with tandem 3 repetition substrates was that the efficiency of bimolecular exon 3 ligation decreased stepwise with each mutation that moved the 5?-greater AG 6 nt downwards, so that RNA 3I was spliced alternatively only 20% efficiently as RNA 3F (Fig.1 C Left).</text>
                    <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="11">
                    <text>An additional observation with tandem containing 3? substrates was that the efficiency of the bimolecular exon ligation decreased step by step with each mutation moving 5?-plus AG 6 nt down, so it is observed that RNA 3I is only 20% as efficiently splice as 3F (Fig.1 C Left).</text>
                    <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="12">
                    <text>An additional observation with tandem containing 3? substrates was that the efficiency of the bimolecular exon ligation decreased step by step with each mutation moving the 5?-plus AG 6 nt down, so that RNA 3I will splice only 20% as efficiently as 3F (Fig.1 C Left).</text>
                    <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="13">
                    <text>An additional observation with tandem containing 3? substrates was that the efficiency of the bimolecular exon ligation decreased step by step with each mutation that moved 5?-plus AG 6 nt down, so RNA 3I has been shown to be splice only 20% as efficient as 3F (Fig.1 C Left).</text>
                    <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="14">
                    <text>An additional observation with tandem containing 3? substrates was that the efficiency of the bimolecular exon ligation decreased step by step with each mutation that moved 5?-plus AG 6 nt down, so that RNA 3I could alternatively have spliced only 20% as efficient as 3F (Fig.1 C Left).</text>
                    <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="15">
                    <text>An additional observation with tandem splice 3? substrates was that the efficiency of the bimolecular exon ligation decreased step by step with each mutation moving 5?-plus AG 6 nt down, so it is observed that RNA 3I alternately splashes only 20% as efficient as 3F (Fig.1 C Left).</text>
                    <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="16">
                    <text>An additional observation with tandem splice 3? substrates was that the efficiency of the bimolecular exon ligation decreased step by step with each mutation moving 5?-plus AG 6 nt down, so that RNA 3I alternatively will only splash 20% as efficiently as 3F (Fig.1 C Left).</text>
                    <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="17">
                    <text>An additional observation with tandem splice 3? substrates was that the efficiency of the bimolecular exon ligation decreased step by step with each mutation moving 5?-plus AG 6 nt down, so that RNA 3I can alternatively divide only 20% as efficient as 3F (Fig.1 C Left).</text>
                    <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="18">
                    <text>An additional observation with tandem splice 3? substrates was that the efficiency of the bimolecular exon ligation decreased step by step with each mutation moving 5?-plus AG 6 nt down, so that RNA 3I has the ability to alternately dodge only 20% as efficient as 3F (Fig.1C Left).</text>
                    <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="19">
                    <text>An additional observation with tandem splice 3? substrates was that the efficiency of the bimolecular exon ligation decreased step by step with each mutation moving the 5?-plus AG 6 nt down, so that RNA 3I is able to alternately divide only 20% as efficient as 3F (Fig.1 C Left).</text>
                    <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="20">
                    <text>An additional observation with tandem spliced 3? substrates was that the efficiency of the bimolecular exon ligation decreased step by step with each mutation moving 5?-plus AG 6 nt down, so RNA 3I alternately only 20% as efficient as 3F (Fig.1 C Left).</text>
                    <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="21">
                    <text>An additional observation with tandem spliced 3? substrates was that the efficiency of the bimolecular exon ligation decreased step by step with each mutation moving 5?-plus AG 6 nt down, so RNA 3I has only plicated 20% as efficient as 3F (Fig.1 C Left).</text>
                    <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="22">
                    <text>An additional observation with tandem spliced 3? substrates was that the efficiency of the bimolecular exon ligation decreased step by step with each mutation that moved the 5?-plus AG 6 nt down, so that RNA 3I could have plicated only 20% as efficient as 3F (Fig.1 C Left).</text>
                    <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="23">
                    <text>An additional observation with tandem splices 3? substrates was that the efficiency of the bimolecular exon ligation decreased step by step with each mutation moving the 5?-plus AG 6 nt down, so that RNA 3I only 20% as efficient as 3F (Fig.1 C Left).</text>
                    <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="24">
                    <text>An additional observation with tandem substrates containing 3? was that the efficiency of the ligation of exon 3 bimolecular decreased step by step with each mutation moving 5?-plus AG 6 nt down, so RNA 3I only spliced 20% as efficiently as 3F (Fig.1 C Left).</text>
                    <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="25">
                    <text>An additional observation with tandem substrates containing 3? was that the efficiency of the ligation of the bimolecular exon 3 decreased step by step with each mutation moving 5?-plus AG 6 nt down, so that it is observed that RNA 3I is only 20% more efficiently splice as 3F (Fig.1 C Left).</text>
                    <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="26">
                    <text>An additional observation with tandem substrates containing 3? was that the efficiency of the ligation of the bimolecular exon 3 decreased step by step with each mutation moving the 5?-plus AG 6 nt down, so that RNA 3I will splice only 20% efficiently as 3F (Fig.1 C Left).</text>
                    <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="27">
                    <text>An additional observation with tandem substrates containing 3? was that the efficiency of the ligation of the bimolecular exon 3 decreased step by step with each mutation that moved 5?-plus AG 6 nt down, so RNA 3I was splice only 20% as efficiently as 3F (Fig.1 C Left).</text>
                    <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="28">
                    <text>An additional observation with tandem substrates containing 3? was that the efficiency of the ligation of the bimolecular exon 3 decreased step by step with each mutation that moved 5?-plus AG 6 nt down, so that RNA 3I could have spliced alternatively only 20% efficiently as 3F (Fig.1 C Left).</text>
                    <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="29">
                    <text>An additional observation with tandem substrates splice 3? was that the efficiency of the ligation of the bimolecular exon 3 decreased step by step with each mutation moving 5?-plus AG 6 nt down, so that RNA 3I alternatively will only splash 20% efficiently as 3F (Fig.1 C Left).</text>
                    <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="30">
                    <text>An additional observation with tandem substrates splice 3? was that the efficiency of the ligation of the bimolecular exon 3 decreased step by step with each mutation moving 5?-plus AG 6 nt down, so that RNA 3I can divide alternatively only 20% as efficient as 3F (Fig.1 C Left).</text>
                    <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="31">
                    <text>An additional observation with tandem substrates splice 3? was that the efficiency of the ligation of the bimolecular exon 3 decreased step by step with each mutation moving 5?-plus AG 6 nt down, so that RNA 3I has the ability to section alternately only 20% as efficiently as 3F (Fig.1C Left).</text>
                    <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="32">
                    <text>An additional observation with tandem substrates splice 3? was that the efficiency of the ligation of the bimolecular exon 3 decreased step by step with each mutation moving 5?-plus AG 6 nt down, so that it is observed that RNA 3I alternately spreads only 20% as efficiently as 3F (Fig.1 C Left).</text>
                    <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="33">
                    <text>An additional observation with tandem substrates splice 3? was that the efficiency of the ligation of the bimolecular exon 3 decreased step by step with each mutation moving the 5?-plus AG 6 nt down, so that RNA 3I is able to alternately divide only 20% as efficient as 3F (Fig.1 C Left).</text>
                    <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="34">
                    <text>An additional observation with tandem substrates spliced 3? was that the efficiency of the ligation of the bimolecular exon 3 decreased step by step with each mutation that moved the 5?-plus AG 6 nt down, so that RNA 3I could have only been able to achieve 20% as efficiently as 3F (Fig.1 C Left).</text>
                    <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="35">
                    <text>An additional observation with tandem substrates splices 3? was that the efficiency of the ligation of the bimolecular exon 3 decreased step by step with each mutation moving the 5?-plus AG 6 nt down, so that RNA 3I only 20% was as efficient as 3F (Fig.1 C Left).</text>
                    <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="36">
                    <text>An additional observation with tandem-repetition substrates 3 was that the efficiency of the bimolecular exon 3 ligation decreased progressively with each mutation that moved the 5?-gre plus AG 6 nt down, so that RNA 3I has the ability to splice only 20% efficiently as 3F RNA (Fig.1 C Left).</text>
                    <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="37">
                    <text>An additional observation with the tandem containing 3? substrates was that the efficiency of the bimolecular exon ligation decreased step by step with each mutation moving 5?-plus AG 6 nt down, so RNA 3I has been splice to alternately only splash 20% as efficiently as 3F (Fig.1 C Left).</text>
                    <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="38">
                    <text>An additional observation with the tandem containing substrates 3? was that the efficiency of the ligation of exon 3 bimolecular decreased step by step with each mutation moving 5?-plus AG 6 nt down, so RNA 3I was shown to splice only 20% efficiently as 3F (Fig.1 C Left).</text>
                    <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="39">
                    <text>An additional observation with the tandem splice 3? substrates was that the efficiency of the bimolecular exon ligation decreased step by step with each mutation moving the 5?-plus AG 6 nt down, so that RNA 3I has the ability to divide only 20% as efficiently as 3F (Fig.1 C Left).</text>
                    <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="40">
                    <text>An additional observation with the tandem splice 3? substrates was that the efficiency of the bimolecular exon ligation decreased step by step with each mutation moving the 5?-plus BG 6 nt down, so MRNA 3I can only divide 20% as efficiently as 3F (Fig.1 C Left).</text>
                    <arg n="2">MRNA 3I</arg>
                </example>
                <example src="EGRAM" no="41">
                    <text>An additional observation with the tandem splice 3? substrates was that the efficiency of the bimolecular exon ligation decreased step by step with each mutation that moved the 5?-plus AG 6 nt down, so that RNA 3I is able to divide only 20% as efficient as 3F (Fig.1 C Left).</text>
                    <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="42">
                    <text>An additional observation with the tandem splices 3? substrates was that the efficiency of the bimolecular exon ligation decreased step by step with each mutation moving the 5?-plus AG 6 nt down, so that RNA 3I alternatively narrows only 20% as efficiently as the 3F RNA (Fig.1 C Left).</text>
                    <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="43">
                    <text>An additional observation with the tandem splices substrates 3? was that the efficiency of the ligation of the bimolecular exon 3 decreased step by step with each mutation moving the 5?-plus AG 6 nt down, so that the alternative RNA 3I narrows only 20% efficiently as the 3F RNA (Fig.1 C Left).</text>
                    <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="44">
                    <text>Consequently, exon 30 with intron has been shown to be spliced.</text>
                    <arg n="1">exon 30 with intron</arg>
                </example>
                <example src="EGRAM" no="45">
                    <text>Consequently, exon 30 with intron is able to be spliced.</text>
                    <arg n="1">exon 30 with intron</arg>
                </example>
                <example src="EGRAM" no="46">
                    <text>Consequently, exon 30 with the intron can be spliced.</text>
                    <arg n="1">exon 30 with the intron</arg>
                </example>
                <example src="EGRAM" no="47">
                    <text>Consequently, exon 30 with the intron can spliced spalated.</text>
                    <arg n="1">exon 30 with the intron</arg>
                </example>
                <example src="EGRAM" no="48">
                    <text>Consequently, exon 30 with the intron has been spliced to be spalmate.</text>
                    <arg n="1">exon 30 with the intron</arg>
                </example>
                <example src="EGRAM" no="49">
                    <text>Consequently, exon 30 with the intron has spliced spalated.</text>
                    <arg n="1">exon 30 with the intron</arg>
                </example>
                <example src="EGRAM" no="50">
                    <text>Consequently, exon 30 with the intron has the ability to spliced spalate.</text>
                    <arg n="1">exon 30 with the intron</arg>
                </example>
                <example src="EGRAM" no="51">
                    <text>Consequently, exon 30 with the intron has the ability to spliced spalated.</text>
                    <arg n="1">exon 30 with the intron</arg>
                </example>
                <example src="EGRAM" no="52">
                    <text>Consequently, exon 30 with the intron is spliced to be blurred.</text>
                    <arg n="1">exon 30 with the intron</arg>
                </example>
                <example src="EGRAM" no="53">
                    <text>Consequently, exon 30 with the intron is spliced to be spalmate.</text>
                    <arg n="1">exon 30 with the intron</arg>
                </example>
                <example src="EGRAM" no="54">
                    <text>Consequently, exon 30 with the intron may have been spliced.</text>
                    <arg n="1">exon 30 with the intron</arg>
                </example>
                <example src="EGRAM" no="55">
                    <text>Consequently, exon 30 with the intron was spliced.</text>
                    <arg n="1">exon 30 with the intron</arg>
                </example>
                <example src="EGRAM" no="56">
                    <text>Consequently, exon 30 with the intron will spliced spalated.</text>
                    <arg n="1">exon 30 with the intron</arg>
                </example>
                <example src="EGRAM" no="57">
                    <text>Consequently, exon 30 with the intron will spliced spleen.</text>
                    <arg n="1">exon 30 with the intron</arg>
                </example>
                <example src="EGRAM" no="58">
                    <text>Consequently, exon 30 with the intron, as suggested by our study can be spliced.</text>
                    <arg n="1">exon 30 with the intron, as suggested by our study</arg>
                </example>
                <example src="EGRAM" no="59">
                    <text>Consequently, exon 30 with the intron, as suggested by our study has been demonstrated to be spliced.</text>
                    <arg n="1">exon 30 with the intron, as suggested by our study</arg>
                </example>
                <example src="EGRAM" no="60">
                    <text>Consequently, exon 30 with the intron, as suggested by our study has spliced spleen.</text>
                    <arg n="1">exon 30 with the intron, as suggested by our study</arg>
                </example>
                <example src="EGRAM" no="61">
                    <text>Consequently, exon 30 with the intron, as suggested by our study is able to be spliced.</text>
                    <arg n="1">exon 30 with the intron, as suggested by our study</arg>
                </example>
                <example src="EGRAM" no="62">
                    <text>Consequently, exon 30 with the intron, as suggested by our study may spliced been seeded.</text>
                    <arg n="1">exon 30 with the intron, as suggested by our study</arg>
                </example>
                <example src="EGRAM" no="63">
                    <text>Consequently, exon 30 with the intron, as suggested by our study will be spliced.</text>
                    <arg n="1">exon 30 with the intron, as suggested by our study</arg>
                </example>
                <example src="EGRAM" no="64">
                    <text>Consequently, exon 30 with the intron, as suggested by our study, can be spliced.</text>
                    <arg n="1">exon 30 with the intron, as suggested by our study,</arg>
                </example>
                <example src="EGRAM" no="65">
                    <text>Consequently, exon 30 with the intron, as suggested by our study, has spliced spalated.</text>
                    <arg n="1">exon 30 with the intron, as suggested by our study,</arg>
                </example>
                <example src="EGRAM" no="66">
                    <text>Consequently, exon 30 with the intron, as suggested by our study, may spliced been spalated.</text>
                    <arg n="1">exon 30 with the intron, as suggested by our study,</arg>
                </example>
                <example src="EGRAM" no="67">
                    <text>Consequently, exon 30 with the intron, as suggested by our study, will spliced spalated.</text>
                    <arg n="1">exon 30 with the intron, as suggested by our study,</arg>
                </example>
                <example src="EGRAM" no="68">
                    <text>Consequently, exon 30 with the intron, as suggested in our study has the ability to spliced spalate.</text>
                    <arg n="1">exon 30 with the intron, as suggested in our study</arg>
                </example>
                <example src="EGRAM" no="69">
                    <text>Consequently, exon 30 with the intron, as suggested in our study has the ability to spliced spalated.</text>
                    <arg n="1">exon 30 with the intron, as suggested in our study</arg>
                </example>
                <example src="EGRAM" no="70">
                    <text>Consequently, exon 30 with the intron, as suggested in our study was spliced.</text>
                    <arg n="1">exon 30 with the intron, as suggested in our study</arg>
                </example>
                <example src="EGRAM" no="71">
                    <text>Consequently, exon 30 with the intron, as suggested in our study, can spliced spalated.</text>
                    <arg n="1">exon 30 with the intron, as suggested in our study,</arg>
                </example>
                <example src="EGRAM" no="72">
                    <text>Consequently, exon 30 with the intron, as suggested in our study, spliced spalted.</text>
                    <arg n="1">exon 30 with the intron, as suggested in our study,</arg>
                </example>
                <example src="EGRAM" no="73">
                    <text>Consequently, it has been spliced that exon 30 with the intron, as suggested by our study, is spalmate.</text>
                    <arg n="1">exon 30 with the intron, as suggested by our study,</arg>
                </example>
                <example src="EGRAM" no="74">
                    <text>Consequently, it is spliced that exon 30 with the intron, as suggested in our study is spalmate.</text>
                    <arg n="1">exon 30 with the intron, as suggested in our study</arg>
                </example>
                <example src="EGRAM" no="75">
                    <text>Consequently, it is spliced that exon 30 with the intron, as suggested in our study, is spalmate.</text>
                    <arg n="1">exon 30 with the intron, as suggested in our study,</arg>
                </example>
                <example src="EGRAM" no="76">
                    <text>El minigen casp-2 (C2) can be efficiently spliced into in vitro, and the ratio of casp-2S to the produced casp-2L mRNA was similar to the observed in vivo (Fig. 1 C, lane 1).</text>
                    <arg n="0">El minigen casp-2 (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="EGRAM" no="77">
                    <text>El minigen casp-2 (C2) is able to be efficiently spliced in vitro, and the ratio of casp-2S to the produced casp-2L mRNA was similar to the observed in vivo (Fig. 1 C, lane 1).</text>
                    <arg n="0">El minigen casp-2 (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="EGRAM" no="78">
                    <text>El minigen casp-2 (C2) may have been efficiently spliced in vitro, and the ratio of casp-2S to the produced casp-2L mRNA was similar to the observed in vivo (Fig. 1 C, lane 1).</text>
                    <arg n="0">El minigen casp-2 (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="EGRAM" no="79">
                    <text>El minigen casp-2 (C2) may have been efficiently spliced into in vitro, and the ratio of casp-2S to the produced casp-2L mRNA was similar to that observed in vivo (Fig. 1 C, lane 1).</text>
                    <arg n="0">El minigen casp-2 (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="EGRAM" no="80">
                    <text>El minigen casp-2 (C2) may have been shown to be efficiently spliced in vitro, and the ratio of casp-2S to the produced casp-2L mRNA was similar to the observed in vivo (Fig. 1 C, lane 1).</text>
                    <arg n="0">El minigen casp-2 (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="EGRAM" no="81">
                    <text>El minigen casp-2 (C2) was efficiently spliced in vitro, and the ratio of casp-2S to the produced casp-2L mRNA was similar to the observed in vivo (Fig. 1 C, lane 1).</text>
                    <arg n="0">El minigen casp-2 (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="EGRAM" no="82">
                    <text>El minigen casp-2 (C2) was observed to be efficiently spliced in vitro, and the ratio of casp-2S to the produced casp-2L mRNA was similar to that observed in vivo (Fig. 1 C, lane 1).</text>
                    <arg n="0">El minigen casp-2 (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="EGRAM" no="83">
                    <text>However, a mNN pre-RNA containing SE2 mutations is able to spliced the use of the splice site nt 3605 3 using predominantly A1.</text>
                    <arg n="0">a mNN pre-RNA containing SE2 mutations</arg>
                    <arg n="1">the splice site nt 3605 3</arg>
                </example>
                <example src="EGRAM" no="84">
                    <text>However, a mutation prior to mRNA containing EE2 will be spliced predominantly by A1 (a spraying site of NT 3605 3.</text>
                    <arg n="0">a mutation prior to mRNA containing EE2</arg>
                </example>
                <example src="EGRAM" no="85">
                    <text>However, a mutation prior to mRNA containing EE2 will be spliced predominantly into A1 (the site of section nt 3605 3.</text>
                    <arg n="0">a mutation prior to mRNA containing EE2</arg>
                </example>
                <example src="EGRAM" no="86">
                    <text>However, a pre-RNA containing SE2 mutations has been shown to be predominantly spliced using the 3 nt spliced site 3605.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">the 3 nt spliced site 3605</arg>
                </example>
                <example src="EGRAM" no="87">
                    <text>However, a pre-RNA containing SE2 mutations has the ability to be spliced predominantly using the splice 3 nt 3605 site.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">the splice 3 nt 3605 site</arg>
                </example>
                <example src="EGRAM" no="88">
                    <text>However, a pre-RNA containing SE2 mutations is able to spliced predominantly using the splice 3 nt 3605 site.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">the splice 3 nt 3605 site</arg>
                </example>
                <example src="EGRAM" no="89">
                    <text>However, a pre-RNA containing SE2 mutations is likely to be spliced more frequently with nt 3605 slice site is a growth factor that can be used in patients with A1 (a pre-RNA containing SE2 mutations).</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">nt 3605</arg>
                </example>
                <example src="EGRAM" no="90">
                    <text>However, a pre-RNA containing SE2 mutations was spliced predominantly by A1 (a spraying site of NT 3605 3.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                </example>
                <example src="EGRAM" no="91">
                    <text>However, a pre-RNA containing mutations in SE2 has the ability to be spliced predominantly with the splice site 3 nt 3605.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the splice site 3 nt 3605</arg>
                </example>
                <example src="EGRAM" no="92">
                    <text>However, a pre-RNA containing mutations in SE2 is alternately spliced predominantly using a 3605 3 coupling site.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">a 3605 3 coupling site</arg>
                </example>
                <example src="EGRAM" no="93">
                    <text>However, a pre-RNA containing mutations in SE2 is predominantly spliced with nt 3605 3 splice site.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">nt 3605 3 splice site</arg>
                </example>
                <example src="EGRAM" no="94">
                    <text>However, a pre-RNA containing mutations in SE2 is predominantly spliced with the 3 nt splice site 3605.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the 3 nt splice site 3605</arg>
                </example>
                <example src="EGRAM" no="95">
                    <text>However, a pre-RNA containing mutations in SE2 was predominantly spliced using the splice nt 3605 site.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the splice nt 3605 site</arg>
                </example>
                <example src="EGRAM" no="96">
                    <text>However, a pre-RNA containing mutations in SE2 was spliced predominantly by A1 (a spraying site of NT 3605 3.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                </example>
                <example src="EGRAM" no="97">
                    <text>However, a pre-mRNA containing mutations in SE2 can be spliced predominantly using the nt 3605 3 splice site.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="EGRAM" no="98">
                    <text>However, a pre-mRNA containing mutations in SE2 has been predominantly spliced using the nt 3605 3 splice site.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="EGRAM" no="99">
                    <text>However, a pre-mRNA containing mutations in SE2 has the ability to be spliced predominantly using the nt 3605 3 splice site.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="EGRAM" no="100">
                    <text>However, a pre-mRNA containing mutations in SE2 is spliced predominantly using the nt 3605 3 splice site.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="EGRAM" no="101">
                    <text>However, a pre-mRNA containing mutations in SE2 may have been spliced predominantly using the nt 3605 3 splice site.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="EGRAM" no="102">
                    <text>However, a pre-mRNA containing mutations in SE2 was predominantly spliced using the nt 3605 3 splice site.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="EGRAM" no="103">
                    <text>However, a pre-mRNA containing mutations in SE2 will be spliced predominantly using the nt 3605 3 splice site.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="EGRAM" no="104">
                    <text>However, a pre-mRNA mutation containing EE2 can be spliced predominantly by A1 (a spraying site of NT 3605 3.</text>
                    <arg n="0">a pre-mRNA mutation containing EE2</arg>
                </example>
                <example src="EGRAM" no="105">
                    <text>However, a pre-mRNA mutation containing EE2 can be spliced predominantly with A1 (a spraying site of NT 3605 3.</text>
                    <arg n="0">a pre-mRNA mutation containing EE2</arg>
                </example>
                <example src="EGRAM" no="106">
                    <text>However, a pre-mRNA mutation containing EE2 may have been predominantly spliced with the site of 3, 505 and 3 splices.</text>
                    <arg n="0">a pre-mRNA mutation containing EE2</arg>
                    <arg n="1">the site of 3, 505 and 3 splices</arg>
                </example>
                <example src="EGRAM" no="107">
                    <text>However, a pre-mRNA mutation containing EE2 was predominantly spliced into A1 (the site of slice nt 3605 3.</text>
                    <arg n="0">a pre-mRNA mutation containing EE2</arg>
                </example>
                <example src="EGRAM" no="108">
                    <text>However, a pre-mRNA mutation containing EE2 was spliced predominantly into A1 (the site of section nt 3605 3.</text>
                    <arg n="0">a pre-mRNA mutation containing EE2</arg>
                </example>
                <example src="EGRAM" no="109">
                    <text>However, a pre-mRNA mutation containing EE2 will predominantly be spliced into A1 (the site of slice nt 3605 3.</text>
                    <arg n="0">a pre-mRNA mutation containing EE2</arg>
                </example>
                <example src="EGRAM" no="110">
                    <text>However, a pre-mRNA that contains mutations in SE2 is able to alternately splic spliced predominantly the nt 3605 3 splice site.</text>
                    <arg n="0">a pre-mRNA that contains mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="EGRAM" no="111">
                    <text>However, it has been shown that a pre-mRNA containing mutations in SE2 is spliced predominantly using the nt 3605 3 splice site.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="EGRAM" no="112">
                    <text>However, it has been spliced that a pre-RNA containing mutations in SE2 is predominantly deployed with nt 3605 3 splice site.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">nt 3605 3 splice site</arg>
                </example>
                <example src="EGRAM" no="113">
                    <text>However, it is likely that a pre-RNA containing SE2 mutations will divide more frequently with the spliced site nt 3605 is a growth factor that can be used in patients with A1 (a pre-RNA containing SE2).</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">nt 3605</arg>
                </example>
                <example src="EGRAM" no="114">
                    <text>However, it is likely that a pre-mRNA containing mutations in SE2 will be spliced predominantly using the nt 3605 3 splice site.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="EGRAM" no="115">
                    <text>However, it is likely that a pre-mRNA mutation containing EE2 is predominantly spliced with nt 3605 slice 3 site.</text>
                    <arg n="0">a pre-mRNA mutation containing EE2</arg>
                    <arg n="1">nt 3605</arg>
                </example>
                <example src="EGRAM" no="116">
                    <text>However, it is observed that a pre-mRNA containing mutations in SE2 is alternatively spliced predominantly using the nt 3605 3 splice site.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="EGRAM" no="117">
                    <text>However, it is observed that a pre-mRNA containing mutations in SE2 is spliced predominantly using the nt 3605 3 splice site.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="EGRAM" no="118">
                    <text>It has been shown that pre-mRNAs of all these genes can be spliced with few or no spatter exon (ref.16; also Fig.1 C and undisplayed data), suggesting that the correct inclusion of the exon can be handled by the yeasts gene expression machinery.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no spatter exon</arg>
                </example>
                <example src="EGRAM" no="119">
                    <text>It has been shown that pre-mRNAs of all these genes can be spliced with little or no exon spatter (ref.16; also Fig. 1 C and data not presented), suggesting that the correct inclusion of exon can be managed by the yeast gene expression machine.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spatter</arg>
                </example>
                <example src="EGRAM" no="120">
                    <text>It has been spliced that a caspasa-2 minigen construction is made with the splicing of transfected cells and nuclear extracts.</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="121">
                    <text>It has been spliced that a caspasa-2 minigen construction is used alternatively in transfected cells and nuclear extracts.</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="122">
                    <text>It has been spliced that the Supt4h gene is usually cut from five exons encoded by chromosome 11.</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="EGRAM" no="123">
                    <text>It is observed that exons outside this range of size requires additional exonic and/or intron sequences to be effectively spliced into mature mRNA.</text>
                    <arg n="1">exons outside this range of size</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="EGRAM" no="124">
                    <text>It is observed that exons outside this range of size requires additional exonic and/or intronic sequences to be spliced into mature mRNA.</text>
                    <arg n="1">exons outside this range of size</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="EGRAM" no="125">
                    <text>It is observed that exons outside this size range requires additional exotic and/or intron sequences to be effectively spliced into mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="EGRAM" no="126">
                    <text>It is observed that exons outside this size range requires additional exotic and/or intronic sequences to be spliced into mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="EGRAM" no="127">
                    <text>It is observed that the Supt4h gene is usually spliced from five exons encoded by chromosome 11.</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="EGRAM" no="128">
                    <text>It is observed that the construction of a caspasa-2 minigen is made from a caspasa-2 minigen construction, which is alternately spliced into transfected cells and nuclear extracts.</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="129">
                    <text>Pre-RNAs of all these genes are able to be spliced with little or no exon-pulping (ref. 16; also Fig. 1 C and data not presented), suggesting that the correct inclusion of exon can be controlled by the yeast genes expression machinery.</text>
                    <arg n="0">Pre-RNAs of all these genes</arg>
                    <arg n="1">little or no exon-pulping</arg>
                </example>
                <example src="EGRAM" no="130">
                    <text>Pre-mRNAs of all these genes are shown to be spliced with few or no exon-spatch (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">Pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatch</arg>
                </example>
                <example src="EGRAM" no="131">
                    <text>Pre-mRNAs of all these genes have been shown to be spliced with few or no exon-spatch (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">Pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatch</arg>
                </example>
                <example src="EGRAM" no="132">
                    <text>Pre-mRNAs of all these genes have the ability to be spliced with few or no exon-spatch (ref.16; also Fig.1 C and undisplayed data), suggesting that the correct inclusion of the exon can be handled by the yeast gene expression machinery.</text>
                    <arg n="0">Pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatch</arg>
                </example>
                <example src="EGRAM" no="133">
                    <text>Pre-mRNAs of all these genes that are able to be spliced with little or no exon-skipping (ref. 16; also Fig. 1 C and data not presented) suggest that the correct inclusion of exon can be controlled by the yeast genes expression machine.</text>
                    <arg n="0">Pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon-skipping</arg>
                </example>
                <example src="EGRAM" no="134">
                    <text>Pre-mRNAs of all these genes that will be spliced with few or no exon-spatch (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by the yeast gene expression machinery.</text>
                    <arg n="0">Pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatch</arg>
                </example>
                <example src="EGRAM" no="135">
                    <text>Pre-mRNAs of all these genes were observed to be spliced with little or no exon-skipping (ref. 16; also Fig. 1 C and data not presented) suggesting that the correct inclusion of exon can be controlled by the yeast genes expression machine.</text>
                    <arg n="0">Pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon-skipping</arg>
                </example>
                <example src="EGRAM" no="136">
                    <text>Supt4h gene can normally be spliced from five exons coded by chromosome 11.</text>
                    <arg n="0">Supt4h gene</arg>
                    <arg n="1">five exons coded by chromosome 11</arg>
                </example>
                <example src="EGRAM" no="137">
                    <text>Supt4h gene has the ability to be normally spliced from five exons coded by chromosome 11.</text>
                    <arg n="0">Supt4h gene</arg>
                    <arg n="1">five exons coded by chromosome 11</arg>
                </example>
                <example src="EGRAM" no="138">
                    <text>Supt4h gene is able to be normally spliced from five exons coded by chromosome 11.</text>
                    <arg n="0">Supt4h gene</arg>
                    <arg n="1">five exons coded by chromosome 11</arg>
                </example>
                <example src="EGRAM" no="139">
                    <text>Supt4h gene is able to be spliced normally from five exons coded by chromosome 11.</text>
                    <arg n="0">Supt4h gene</arg>
                    <arg n="1">five exons coded by chromosome 11</arg>
                </example>
                <example src="EGRAM" no="140">
                    <text>Supt4h gene is able to normally be spliced from five exons coded by chromosome 11.</text>
                    <arg n="0">Supt4h gene</arg>
                    <arg n="1">five exons coded by chromosome 11</arg>
                </example>
                <example src="EGRAM" no="141">
                    <text>Supt4h gene is observed as normally spliced from five exons coded by chromosome 11.</text>
                    <arg n="0">Supt4h gene</arg>
                    <arg n="1">five exons coded by chromosome 11</arg>
                </example>
                <example src="EGRAM" no="142">
                    <text>Supt4h gene is observed to be normally spliced from five exons coded by chromosome 11.</text>
                    <arg n="0">Supt4h gene</arg>
                    <arg n="1">five exons coded by chromosome 11</arg>
                </example>
                <example src="EGRAM" no="143">
                    <text>Supt4h gene may have been normally spliced from five exons coded by chromosome 11.</text>
                    <arg n="0">Supt4h gene</arg>
                    <arg n="1">five exons coded by chromosome 11</arg>
                </example>
                <example src="EGRAM" no="144">
                    <text>Supt4h gene may have been spliced normally from five exons coded by chromosome 11.</text>
                    <arg n="0">Supt4h gene</arg>
                    <arg n="1">five exons coded by chromosome 11</arg>
                </example>
                <example src="EGRAM" no="145">
                    <text>Supt4h gene was normally spliced from five exons coded by chromosome 11.</text>
                    <arg n="0">Supt4h gene</arg>
                    <arg n="1">five exons coded by chromosome 11</arg>
                </example>
                <example src="EGRAM" no="146">
                    <text>Supt4h gene will normally be spliced from five exons coded by chromosome 11.</text>
                    <arg n="0">Supt4h gene</arg>
                    <arg n="1">five exons coded by chromosome 11</arg>
                </example>
                <example src="EGRAM" no="147">
                    <text>The A0 gene (Supt4h) has the ability to be normally spliced from five exons encoded by chromosome 11.</text>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="EGRAM" no="148">
                    <text>The A0 was made (a caspasa-2 minigen construction) that was alternatively spliced into transfected cells and nuclear extracts.</text>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="149">
                    <text>The Pre-mRNA of all these genes spliced to be deployed with small or no exon escapement (ref. 16; also Fig. 1 C and data not presented) suggests that the correct inclusion of the exon can be controlled by the yeast gene expression machine.</text>
                    <arg n="0">Pre-mRNA of all these genes</arg>
                    <arg n="1">small or no exon escapement</arg>
                </example>
                <example src="EGRAM" no="150">
                    <text>The minigene casp-2 (C2) has the ability to be efficiently spliced in vitro, and the ratio of casp-2S with the casp-2L mRNA produced was similar to that observed in vivo (Fig. 1 C, lane 1).</text>
                    <arg n="0">The minigene casp-2 (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="EGRAM" no="151">
                    <text>The minigene casp-2 (C2) has the ability to be efficiently spliced in vitro, and the ratio of casp-2S with the casp-2L mRNAs produced was similar to that observed in vivo (Fig. 1 C, lane 1).</text>
                    <arg n="0">The minigene casp-2 (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="EGRAM" no="152">
                    <text>The minigene casp-2 (C2) is able to be efficiently spliced in vitro, and the ratio of casp-2S with the casp-2L mRNA produced was similar to that observed in vivo (Fig. 1 C, lane 1).</text>
                    <arg n="0">The minigene casp-2 (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="EGRAM" no="153">
                    <text>The minigene casp-2 (C2) is efficiently spliced in vitro, and the ratio of casp-2S with the casp-2L mRNA produced was similar to that observed in vivo (Fig. 1 C, lane 1).</text>
                    <arg n="0">The minigene casp-2 (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="EGRAM" no="154">
                    <text>The minigene casp-2 (C2) may have been demonstrated to be efficiently spliced in vitro, and the ratio of casp-2S with the casp-2L mRNA produced was similar to that observed in vivo (Fig. 1 C, lane 1).</text>
                    <arg n="0">The minigene casp-2 (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="EGRAM" no="155">
                    <text>The minigene casp-2 (C2) was efficiently spliced in vitro, and the ratio of casp-2S with the casp-2L mRNAs produced was similar to that observed in vivo (Fig. 1 C, lane 1).</text>
                    <arg n="0">The minigene casp-2 (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="EGRAM" no="156">
                    <text>The minigene casp-2 (C2) was observed to be efficiently spliced in vitro, and the ratio of casp-2S with the casp-2L mRNAs produced was similar to that observed in vivo (Fig. 1 C, lane 1).</text>
                    <arg n="0">The minigene casp-2 (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="EGRAM" no="157">
                    <text>The minigene casp-2 (C2) will be efficiently spliced in vitro, and the ratio of casp-2S with the casp-2L mRNA produced was similar to that observed in vivo (Fig. 1 C, lane 1).</text>
                    <arg n="0">The minigene casp-2 (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="EGRAM" no="158">
                    <text>The mouse polymer immunoglobulin receptor gene has the ability to be efficiently spliced into an exon 654 nt which has the ability to be penetrated into mRNA.</text>
                    <arg n="1">an exon 654 nt</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="EGRAM" no="159">
                    <text>The mouse polymeric immunoglobulin receptor gene has an exon 654 nt that has been shown to be efficiently spliced into mRNA.</text>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="EGRAM" no="160">
                    <text>The mouse polymeric immunoglobulin receptor gene has an exon 654 nt that has been spliced to be efficiently penetrated into mRNA.</text>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="EGRAM" no="161">
                    <text>The mouse polymeric immunoglobulin receptor gene has an exon 654 nt that is observed to be effectively spliced into mRNA.</text>
                    <arg n="1">an exon 654 nt</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="EGRAM" no="162">
                    <text>The mouse polymeric immunoglobulin receptor gene has an exon nt 654 that can be efficiently spliced into mRNA.</text>
                    <arg n="1">an exon nt 654</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="EGRAM" no="163">
                    <text>The mouse polymeric immunoglobulin receptor gene has an exon nt 654 that has been efficiently spliced into mRNA.</text>
                    <arg n="1">an exon nt 654</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="EGRAM" no="164">
                    <text>The mouse polymeric immunoglobulin receptor gene has an exon nt 654 that will be efficiently spliced into mRNA.</text>
                    <arg n="1">an exon nt 654</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="EGRAM" no="165">
                    <text>The mouse polymeric immunoglobulin receptor gene has an exon nt 654 which is efficiently spliced into mRNA.</text>
                    <arg n="1">an exon nt 654</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="EGRAM" no="166">
                    <text>The mouse polymeric immunoglobulin receptor gene has exon 654 nt being able to be efficiently spliced into mRNA.</text>
                    <arg n="1">exon 654 nt</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="EGRAM" no="167">
                    <text>The mouse polymeric immunoglobulin receptor gene has exon 654 nt being able to be spliced efficiently into mRNA.</text>
                    <arg n="1">exon 654 nt</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="EGRAM" no="168">
                    <text>The mouse polymeric immunoglobulin receptor gene has exon 654 nt demonstrated to be efficiently spliced into mRNA.</text>
                    <arg n="1">exon 654 nt</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="EGRAM" no="169">
                    <text>The mouse polymeric immunoglobulin receptor gene has exon 654 nt that has been efficiently spliced to mRNA.</text>
                    <arg n="1">exon 654 nt</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="EGRAM" no="170">
                    <text>The mouse polymeric immunoglobulin receptor gene has exon 654 nt that has been observed to be efficiently spliced into mRNA.</text>
                    <arg n="1">exon 654 nt</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="EGRAM" no="171">
                    <text>The mouse polymeric immunoglobulin receptor gene has exon 654 nt that has been spliced to be efficient for its application in mRNA.</text>
                    <arg n="1">exon 654 nt</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="EGRAM" no="172">
                    <text>The mouse polymeric immunoglobulin receptor gene has exon 654 nt that is able to be efficiently spliced into mRNA.</text>
                    <arg n="1">exon 654 nt</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="EGRAM" no="173">
                    <text>The mouse polymeric immunoglobulin receptor gene has exon 654 nt that is observed to be efficiently spliced into mRNA.</text>
                    <arg n="1">exon 654 nt</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="EGRAM" no="174">
                    <text>The mouse polymeric immunoglobulin receptor gene has exon of 654 nt which is efficiently spliced into mRNA.</text>
                    <arg n="1">exon of 654 nt</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="EGRAM" no="175">
                    <text>The mouse polymeric immunoglobulin receptor gene has the ability to be efficiently spliced into mRNA.</text>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="EGRAM" no="176">
                    <text>The mouses polymeric immunoglobulin receptor gene has a 654 nt exon that can be efficiently spliced into the mRNA.</text>
                    <arg n="1">a 654 nt exon</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="177">
                    <text>The mouses polymeric immunoglobulin receptor gene has a 654 nt exon that has been efficiently spliced into the mRNA.</text>
                    <arg n="1">a 654 nt exon</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="178">
                    <text>The mouses polymeric immunoglobulin receptor gene has a 654 nt exon that has been efficiently spliced to the mRNA.</text>
                    <arg n="1">a 654 nt exon</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="179">
                    <text>The mouses polymeric immunoglobulin receptor gene has a 654 nt exon that has the ability to be efficiently spliced into the mRNA.</text>
                    <arg n="1">a 654 nt exon</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="180">
                    <text>The mouses polymeric immunoglobulin receptor gene has a 654 nt exon that was efficiently spliced into the mRNA.</text>
                    <arg n="1">a 654 nt exon</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="181">
                    <text>The mouses polymeric immunoglobulin receptor gene has a 654 nt exon that was efficiently spliced to the mRNA.</text>
                    <arg n="1">a 654 nt exon</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="182">
                    <text>The mouses polymeric immunoglobulin receptor gene has a 654 nt exon that will be efficiently spliced into the mRNA.</text>
                    <arg n="1">a 654 nt exon</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="183">
                    <text>The mouses polymeric immunoglobulin receptor gene has a 654 nt exon which is observed to be efficiently spliced into the mRNA.</text>
                    <arg n="1">a 654 nt exon</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="184">
                    <text>The mouses polymeric immunoglobulin receptor gene has an exon 654 nt that has the ability to be efficiently spliced into the mRNA.</text>
                    <arg n="1">an exon 654 nt</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="185">
                    <text>The mouses polymeric immunoglobulin receptor gene has an exon 654 nt which has been spliced to be efficiently penetrated into mRNA.</text>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="EGRAM" no="186">
                    <text>The mouses polymeric immunoglobulin receptor gene has an exon 654 nt which has been spliced to divide efficiently into mRNA.</text>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="EGRAM" no="187">
                    <text>The mouses polymeric immunoglobulin receptor gene has an exon 654 nt which has the ability to be efficiently spliced into the mRNA.</text>
                    <arg n="1">an exon 654 nt</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="188">
                    <text>The mouses polymeric immunoglobulin receptor gene has an exon 654 nt which is observed to be effectively spliced into the mRNA.</text>
                    <arg n="1">an exon 654 nt</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="189">
                    <text>The mouses polymeric immunoglobulin receptor gene has an exon nt 654 that can be efficiently spliced into the mRNA.</text>
                    <arg n="1">an exon nt 654</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="190">
                    <text>The mouses polymeric immunoglobulin receptor gene has an exon nt 654 that has been efficiently spliced into the mRNA.</text>
                    <arg n="1">an exon nt 654</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="191">
                    <text>The mouses polymeric immunoglobulin receptor gene has an exon nt 654 that is capable of being efficiently spliced into the mRNA.</text>
                    <arg n="1">an exon nt 654</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="192">
                    <text>The mouses polymeric immunoglobulin receptor gene has an exon nt 654 that is efficiently spliced into the mRNA.</text>
                    <arg n="1">an exon nt 654</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="193">
                    <text>The mouses polymeric immunoglobulin receptor gene has an exon nt 654 that may spliced been efficiently spalated in the mRNA.</text>
                    <arg n="1">an exon nt 654</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="194">
                    <text>The mouses polymeric immunoglobulin receptor gene has an exon nt 654 that will be efficiently spliced into the mRNA.</text>
                    <arg n="1">an exon nt 654</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="195">
                    <text>The mouses polymeric immunoglobulin receptor gene has an exon of 654 nt having been efficiently spliced into the mRNA.</text>
                    <arg n="1">an exon of 654 nt</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="196">
                    <text>The mouses polymeric immunoglobulin receptor gene has an exon of 654 nt observed to be effectively spliced into the mRNA.</text>
                    <arg n="1">an exon of 654 nt</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="197">
                    <text>The mouses polymeric immunoglobulin receptor gene has an exon of 654 nt that is efficiently spliced into the mRNA.</text>
                    <arg n="1">an exon of 654 nt</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="198">
                    <text>The mouses polymeric immunoglobulin receptor gene has exon 654 nt efficiently spliced in mRNA.</text>
                    <arg n="1">exon 654 nt</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="EGRAM" no="199">
                    <text>The mouses polymeric immunoglobulin receptor gene has exon 654 nt that is efficiently spliced in mRNA.</text>
                    <arg n="1">exon 654 nt</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="EGRAM" no="200">
                    <text>The mouses polymeric immunoglobulin receptor gene has exon 654 nt which can be efficiently spliced into mRNA.</text>
                    <arg n="1">exon 654 nt</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="EGRAM" no="201">
                    <text>The mouses polymeric immunoglobulin receptor gene has exon 654 nt which has been efficiently spliced into mRNA.</text>
                    <arg n="1">exon 654 nt</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="EGRAM" no="202">
                    <text>The mouses polymeric immunoglobulin receptor gene has exon 654 nt which may have been efficiently spliced into mRNA.</text>
                    <arg n="1">exon 654 nt</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="EGRAM" no="203">
                    <text>The mouses polymeric immunoglobulin receptor gene has exon 654 nt which will be efficiently spliced into mRNA.</text>
                    <arg n="1">exon 654 nt</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="EGRAM" no="204">
                    <text>The mouses polymeric immunoglobulin receptor gene spliced an exon nt 654 efficiently spalated in the mRNA.</text>
                    <arg n="1">an exon nt 654</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="205">
                    <text>The polymeric immunoglobulin receptor gene in mice has exon 654 nt that has been efficiently spliced into mRNA.</text>
                    <arg n="1">exon 654 nt</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="EGRAM" no="206">
                    <text>The polymeric immunoglobulin receptor gene in mice has exon of 654 nt that has been efficiently spliced into mRNA.</text>
                    <arg n="1">exon of 654 nt</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="EGRAM" no="207">
                    <text>The pre-mRNAs of all these genes may have been spliced with few or no spatter exon (ref.16; also Fig.1 C and undisplayed data), suggesting that the correct inclusion of the exon can be handled by the yeasts gene expression machinery.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no spatter exon</arg>
                </example>
                <example src="EGRAM" no="208">
                    <text>The pre-mRNAs of all these genes splashed with few or no exon-spatch (ref.16; also Fig.1 C and undisplayed data) suggests that the correct inclusion of the exon can be spliced by yeast gene expression machinery.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatch</arg>
                </example>
                <example src="EGRAM" no="209">
                    <text>The pre-mRNAs of all these genes that have been pinned with few or no exon-spatched (ref.16; also Fig.1 C and undisplayed data) suggests that the correct inclusion of the exon can be spliced by the yeasts gene expression machinery.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatched</arg>
                </example>
                <example src="EGRAM" no="210">
                    <text>The pre-mRNAs of all these genes will be spliced with few or no exon-spatched (ref.16; also Fig.1 C and undisplayed data), suggesting that the correct inclusion of the exon can be handled by the yeasts gene expression machinery.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatched</arg>
                </example>
                <example src="EGRAM" no="211">
                    <text>The structure of different cDNA clones indicates that USF RNA can be spliced differently, and the alternative use of exon can regulate the functional USF protein levels.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="EGRAM" no="212">
                    <text>The structure of different cDNA clones indicates that USF RNA can be spliced, and the alternative use of exon can regulate the functional USF protein levels.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="EGRAM" no="213">
                    <text>The structure of different cDNA clones indicates that USF RNA can be spliced, and the alternative use of exons can regulate the functional USF protein levels.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="EGRAM" no="214">
                    <text>The structure of different cDNA clones indicates that USF RNA has been demonstrated to be spliced, and the alternative use of exon can regulate the functional USF protein levels.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="EGRAM" no="215">
                    <text>The structure of different cDNA clones indicates that USF RNA has been shown to be differentially spliced, and the alternative use of exons can regulate functional USF protein levels.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="EGRAM" no="216">
                    <text>The structure of different cDNA clones indicates that USF RNA has been shown to be spliced, and the alternative use of exon can regulate the functional USF protein levels.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="EGRAM" no="217">
                    <text>The structure of different cDNA clones indicates that USF RNA has been spliced differently, and the alternative use of exon can regulate the functional USF protein levels.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="EGRAM" no="218">
                    <text>The structure of different cDNA clones indicates that USF RNA has the ability to be spliced, and the alternative use of exon can regulate the functional USF protein levels.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="EGRAM" no="219">
                    <text>The structure of different cDNA clones indicates that USF RNA has the ability to be spliced, and the alternative use of exons can regulate the functional levels of USF protein.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="EGRAM" no="220">
                    <text>The structure of different cDNA clones indicates that USF RNA is able to be spliced, and the alternative use of exon can regulate the functional USF protein levels.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="EGRAM" no="221">
                    <text>The structure of different cDNA clones indicates that USF RNA is capable of being spliced, and the alternative use of exon can regulate the functional USF protein levels.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="EGRAM" no="222">
                    <text>The structure of different cDNA clones indicates that USF RNA is observed as being spliced, and the alternative use of exon can regulate the functional USF protein levels.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="EGRAM" no="223">
                    <text>The structure of different cDNA clones indicates that USF RNA is observed to be differentially spliced, and the alternative use of exons can regulate functional USF protein levels.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="EGRAM" no="224">
                    <text>The structure of different cDNA clones indicates that USF RNA is spliced to be spalmate, and the alternative use of exons can regulate the functional USF protein levels.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="EGRAM" no="225">
                    <text>The structure of different cDNA clones indicates that USF RNA may have been spliced, and the alternative use of exon may regulate the functional USF protein levels.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="EGRAM" no="226">
                    <text>The structure of different cDNA clones indicates that USF RNA may have been spliced, and the alternative use of exons may regulate the functional USF protein levels.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="EGRAM" no="227">
                    <text>The structure of different cDNA clones indicates that USF RNA was differentially spliced, and the alternative use of exons can regulate the functional USF protein levels.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="EGRAM" no="228">
                    <text>The structure of different cDNA clones indicates that USF RNA will be differentially spliced, and the alternative use of exons can regulate the functional USF protein levels.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="EGRAM" no="229">
                    <text>The structure of different cDNA clones indicates that USF RNA will be spliced differently, and the alternative use of exon can regulate the functional USF protein levels.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="EGRAM" no="230">
                    <text>The structure of different cDNA clones indicates that USF RNA will be spliced, and the alternative use of exons may regulate the functional USF protein levels.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="EGRAM" no="231">
                    <text>The structure of different cDNA clones spliced that USF RNA has been blurred, and the alternative use of exon can regulate the functional USF protein levels.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="EGRAM" no="232">
                    <text>The structure of different cDNA clones spliced that USF RNA has been blurred, and the alternative use of exons can regulate the functional USF protein levels.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="EGRAM" no="233">
                    <text>The structure of different cDNA clones spliced that USF RNA has been differentially plicated, and the alternative use of exons can regulate the functional USF protein levels.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="EGRAM" no="234">
                    <text>The structure of different cDNA clones spliced that USF RNA has been pulsed, and the alternative use of exon can regulate the functional USF protein levels.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="EGRAM" no="235">
                    <text>The structure of different cDNA clones spliced that USF RNA has been pulsed, and the alternative use of exons can regulate the functional USF protein levels.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="EGRAM" no="236">
                    <text>The structure of different cDNA clones spliced that USF RNA has the ability to be palatined, and the alternative use of exons can regulate the protein levels of functional USF.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="EGRAM" no="237">
                    <text>The structure of different cDNA clones spliced that USF RNA is able to cause differential splicing, and the alternative use of exon can regulate the functional levels of USF protein.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="EGRAM" no="238">
                    <text>The structure of different cDNA clones spliced that USF RNA is able to spray, and the alternative use of exons can regulate the functional USF protein levels.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="EGRAM" no="239">
                    <text>The structure of different cDNA clones spliced that USF RNA may be differential coupling, and the alternative use of exons may regulate the functional USF protein levels.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="EGRAM" no="240">
                    <text>The structure of different cDNA clones spliced that USF RNA may have been blurred, and the alternative use of exon may regulate the functional USF protein levels.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="EGRAM" no="241">
                    <text>The structure of different cDNA clones spliced that USF RNA may have been blurred, and the alternative use of exons may regulate the functional USF protein levels.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="EGRAM" no="242">
                    <text>The structure of different cDNA clones spliced that USF RNA will be blurred, and the alternative use of exon can regulate the functional USF protein levels.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="EGRAM" no="243">
                    <text>The structure of the different cDNA DNA clones indicates that USF RNA has been shown to be spliced, and alternative use of the exon may regulate functional levels of USF proteins.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="EGRAM" no="244">
                    <text>The structure of the different cDNA DNA clones indicates that USF RNA has been spliced, and alternative use of the exon may regulate functional levels of USF proteins.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="EGRAM" no="245">
                    <text>The structure of the different cDNA DNA clones indicates that USF RNA is spliced to be deployed, and the alternative use of the exon can regulate functional levels of USF proteins.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="EGRAM" no="246">
                    <text>The the casp-2 minigen (C2) can be efficiently spliced in vitro , and the ratio of casp-2S to the produced casp-2L mRNA was similar to the observed in vivo (Fig.1 C, lane 1).</text>
                    <arg n="0">the casp-2 minigen (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="EGRAM" no="247">
                    <text>The the casp-2 minigen (C2) has been efficiently spliced in vitro , and the ratio of casp-2S to the produced casp-2L mRNA was similar to the observed in vivo (Fig.1 C, lane 1).</text>
                    <arg n="0">the casp-2 minigen (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="EGRAM" no="248">
                    <text>The the casp-2 minigen (C2) has been efficiently spliced in vitro, and the relationship between the CASp-2 and casp-2L mRNAs produced was similar to the observed in vivo (Fig.1 C, lane 1).</text>
                    <arg n="0">the casp-2 minigen (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="EGRAM" no="249">
                    <text>The the casp-2 minigen (C2) is efficiently spliced in vitro, and the relationship between the CASp-2 and casp-2L mRNAs produced was similar to the observed in vivo (Fig.1 C, lane 1).</text>
                    <arg n="0">the casp-2 minigen (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="EGRAM" no="250">
                    <text>The the casp-2 minigen (C2) may have been efficiently spliced in vitro, and the ratio of casp-2S to the produced casp-2L mRNA was similar to the observed in vivo (Fig.1 C, lane 1).</text>
                    <arg n="0">the casp-2 minigen (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="EGRAM" no="251">
                    <text>The the casp-2 minigen (C2) will be efficiently spliced in vitro , and the ratio of casp-2S to the produced casp-2L mRNA is similar to the observed in vivo (Fig.1 C, lane 1).</text>
                    <arg n="0">the casp-2 minigen (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="EGRAM" no="252">
                    <text>The the casp-2 minigen (C2) will be efficiently spliced in vitro , and the relationship between the CASp-2 and CASp-2L mRNAs produced is similar to the observed in vivo (Fig.1 C, lane 1).</text>
                    <arg n="0">the casp-2 minigen (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="EGRAM" no="253">
                    <text>We also identified four transcriptional units that could have been differentially spliced but did not contain any obvious open reading framework.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="254">
                    <text>We also identified four transcriptional units that could have been differentially spliced, but did not contain any obvious open reading frame.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="255">
                    <text>We also identified four transcriptional units that may have been spliced differently, but that do not contain any obvious open reading frame.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="256">
                    <text>We also identified four transcriptional units that were differentially spliced but did not contain any obvious open reading framework.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="257">
                    <text>We also identified four transcriptional units that were differentially spliced, but did not contain any obvious open reading frame.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="258">
                    <text>We also identified four transcriptional units that were spliced differently, but do not contain any obvious open reading frame.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="259">
                    <text>We also identified four transcriptional units that were spliced, but do not contain any obvious open reading frame.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="260">
                    <text>We also identified four transcriptive units that are observed as being of spliced tissue, but do not contain any obvious open reading frame.</text>
                    <arg n="0">four transcriptive units</arg>
                </example>
                <example src="EGRAM" no="261">
                    <text>We also identified four transcriptive units that were observed as being differentially spliced, but do not contain an open reading table.</text>
                    <arg n="0">four transcriptive units</arg>
                </example>
                <example src="EGRAM" no="262">
                    <text>We also identify four transcriptional units being able to be spliced, but without a clear open reading structure.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="263">
                    <text>We also identify four transcriptional units being able to be spliced, but without an obvious open reading.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="264">
                    <text>We also identify four transcriptional units that are able to be spliced, but do not have an obvious open reading structure.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="265">
                    <text>We also identify four transcriptional units that are spliced as being unfolded, but they do not have an open reading table.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="266">
                    <text>We also identify four transcriptional units that can be differentially spliced, but do not contain any obvious open reading frame.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="267">
                    <text>We also identify four transcriptional units that can be spliced differently, but do not contain any obvious open reading frame.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="268">
                    <text>We also identify four transcriptional units that can be spliced, but do not contain an obvious open reading structure.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="269">
                    <text>We also identify four transcriptional units that can be spliced, but do not contain any obvious open reading frame.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="270">
                    <text>We also identify four transcriptional units that may have been spread, but does not spliced any obvious open reading frame.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="271">
                    <text>We also identify four transcriptional units that will be spliced differently, but do not contain any obvious open reading frame.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="272">
                    <text>We also identify four transcriptional units that will be spliced, but do not contain any obvious open reading frame.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="273">
                    <text>We also identify four transcriptive units that are able to be differentially spliced, but do not have an obvious open reading structure.</text>
                    <arg n="0">four transcriptive units</arg>
                </example>
                <example src="EGRAM" no="274">
                    <text>We also spliced four transcriptional units blurred, but without obvious open reading frame.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="275">
                    <text>We also spliced four transcriptional units that could have been spread, but did not contain any obvious open reading frame.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="276">
                    <text>We also spliced four transcriptional units that proved to be differentially from each other, but does not contain any obvious open reading frame.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="277">
                    <text>We also spliced four transcriptional units that were different from each other, but do not contain any open obvious reading frame.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="278">
                    <text>We also spliced four transcriptional units that were found to be blurred, but did not contain an obvious open reading structure.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="279">
                    <text>We also spliced four transcriptional units that were found to be blurred, but without a clear open reading structure.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="280">
                    <text>We also spliced four transcriptional units that were spalmated but did not contain any obvious open reading framework.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="281">
                    <text>We also spliced four transcriptional units that were spread, but did not contain any obvious open reading frame.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="282">
                    <text>We also spliced four transcriptional units with differential splicing, but without a clear open reading structure.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="283">
                    <text>We also spliced that four transcriptional units is able to cause differential splicing, but does not contain any obvious open reading frame.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="284">
                    <text>We have also identified four transcriptional units spliced but without an obvious open reading framework.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="285">
                    <text>We have also identified four transcriptional units that can be differentially spliced but do not contain any obvious open reading framework.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="286">
                    <text>We have also identified four transcriptional units that can be spliced but do not contain any obvious open reading framework.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="287">
                    <text>We have also identified four transcriptional units that has been spliced to be differentially interwoven but does not contain any obvious open reading framework.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="288">
                    <text>We have also identified four transcriptional units that have been differentially spliced but do not contain any obvious open reading framework.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="289">
                    <text>We have also identified four transcriptional units that have been observed to be differentially spliced but contain no obvious open reading framework.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="290">
                    <text>We have also identified four transcriptional units that have been spliced but do not contain any obvious open reading framework.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="291">
                    <text>We have also identified four transcriptional units that have been spliced to be differentially interwoven but do not contain any obvious open reading framework.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="292">
                    <text>We have also identified four transcriptional units that may have been differentially spliced, but that do not contain any obvious open reading framework.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="293">
                    <text>We have also identified four transcriptional units that will be differentially spliced but do not contain any obvious open reading framework.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="294">
                    <text>We have also identified four transcriptional units which has been spliced to be spalmated but does not contain any obvious open reading framework.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="295">
                    <text>We have also spliced four transcriptional units that are observed to be differentially interwoven but do not contain any obvious open reading framework.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="296">
                    <text>We have also spliced four transcriptional units that could have been spalmated but did not contain any obvious open reading framework.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="297">
                    <text>We have also spliced four transcriptional units that may have been spalted but does not contain any obvious open reading framework.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="298">
                    <text>We have also spliced four transcriptional units that will be cut but do not contain any obvious open reading framework.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="299">
                    <text>We have also spliced four transcriptional units with differential splicing, but without an obvious open reading frame.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="300">
                    <text>We have also spliced that four transcriptional units can be spalated but does not contain any obvious open reading framework.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="301">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, C2Gloi2 substrate can be divided predominantly by following exonon escaping pathway to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2).</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon escaping pathway</arg>
                </example>
                <example src="EGRAM" no="302">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, C2Gloi2 substrate can be divided predominantly following the A1 level (exonon scaling route) to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                </example>
                <example src="EGRAM" no="303">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, C2Gloi2 substrate can be inclined following exonon escaping route to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon escaping route</arg>
                </example>
                <example src="EGRAM" no="304">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, C2Gloi2 substrate has the ability to be divided following via exon-skipping to a level similar to that obtained with C2 substrate (data not shown and Fig. 2 E, compare lane 3 with lane 1).</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">via exon-skipping</arg>
                </example>
                <example src="EGRAM" no="305">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, C2Gloi2 substrate has the ability to be divided predominantly following via exon-skipping to a level similar to that obtained with C2 substrate (data not shown and Fig. 2 E, compare lane 3 with lane 1).</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">via exon-skipping</arg>
                </example>
                <example src="EGRAM" no="306">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, C2Gloi2 substrate is able to be deployed following exonon scaling route to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon scaling route</arg>
                </example>
                <example src="EGRAM" no="307">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, C2Gloi2 substrate may have been deployed predominantly following exonon escaping route to a level similar to that obtained with C2 substrate (unexposed data and Fig.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon escaping route</arg>
                </example>
                <example src="EGRAM" no="308">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, C2Gloi2 substrate may have been imputed following exonon scaling route to a level similar to that obtained with C2 substrate (unexposed data and Fig.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon scaling route</arg>
                </example>
                <example src="EGRAM" no="309">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, C2Gloi2 substrate will be deployed predominantly following exon-skipping to a level similar to that obtained with C2 substrate (data not shown and Fig. 2).</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exon-skipping</arg>
                </example>
                <example src="EGRAM" no="310">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, it has been shown that C2Gloi2 substrate is predominantly unfolded after exon escaping route at a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exon escaping route</arg>
                </example>
                <example src="EGRAM" no="311">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, it is observed that C2Gloi2 substrate is deployed following exon-skipping to a level similar to that obtained with C2 substrate (data not shown and Fig. 2).</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exon-skipping</arg>
                </example>
                <example src="EGRAM" no="312">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, it is observed that C2Gloi2 substrate is predominantly deployed following exon-skipping to a level similar to that obtained with C2 substrate (data not shown and Fig. 2).</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exon-skipping</arg>
                </example>
                <example src="EGRAM" no="313">
                    <text>When incubated in nuclear extracts or spliced into HeLa cells, C2Gloi2 substrate is divided following exonon scaling route to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon scaling route</arg>
                </example>
                <example src="EGRAM" no="314">
                    <text>When incubated in nuclear extracts or spliced into HeLa cells, C2Gloi2 substrate is predominantly sectioned following exonon escaping route to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 and compares line 3 to line 1.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon escaping route</arg>
                </example>
                <example src="EGRAM" no="315">
                    <text>When incubated in nuclear extracts or spliced into HeLa cells, C2Gloi2 substrate is predominantly sectioned following exonon scaling route to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon scaling route</arg>
                </example>
                <example src="EGRAM" no="316">
                    <text>When incubated in nuclear extracts or spliced into HeLa cells, C2Gloi2 substrate will be inclined after exon escaping route to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compared to lane 3 to lane 1).</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exon escaping route</arg>
                </example>
                <example src="EGRAM" no="317">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, it has been shown that C2Gloi2 substrate is spliced after exonon escaping route at a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon escaping route</arg>
                </example>
                <example src="EGRAM" no="318">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, it has been shown that substrate C2Gloi2 is spliced after exon escapement pathway at a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">substrate C2Gloi2</arg>
                    <arg n="1">exon escapement pathway</arg>
                </example>
                <example src="EGRAM" no="319">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, it has been shown that substrate C2Gloi2 is spliced predominantly after the exon escapement pathway at a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">substrate C2Gloi2</arg>
                    <arg n="1">the exon escapement pathway</arg>
                </example>
                <example src="EGRAM" no="320">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, substrate C2Gloi2 can be spliced following the exon escapement pathway to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">substrate C2Gloi2</arg>
                    <arg n="1">the exon escapement pathway</arg>
                </example>
                <example src="EGRAM" no="321">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, substrate C2Gloi2 can be spliced predominantly by following exon escapement pathway to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">substrate C2Gloi2</arg>
                    <arg n="1">exon escapement pathway</arg>
                </example>
                <example src="EGRAM" no="322">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, substrate C2Gloi2 can be spliced predominantly by following the exon escapement pathway to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compare line 3 with line 1).</text>
                    <arg n="0">substrate C2Gloi2</arg>
                    <arg n="1">the exon escapement pathway</arg>
                </example>
                <example src="EGRAM" no="323">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, substrate C2Gloi2 is able to be spliced following the exon escapement pathway to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">substrate C2Gloi2</arg>
                    <arg n="1">the exon escapement pathway</arg>
                </example>
                <example src="EGRAM" no="324">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, substrate C2Gloi2 is spliced following the exon escapement pathway to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">substrate C2Gloi2</arg>
                    <arg n="1">the exon escapement pathway</arg>
                </example>
                <example src="EGRAM" no="325">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, substrate C2Gloi2 is spliced predominantly following the exon escapement pathway to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">substrate C2Gloi2</arg>
                    <arg n="1">the exon escapement pathway</arg>
                </example>
                <example src="EGRAM" no="326">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, substrate C2Gloi2 will be spliced after the exon escapement pathway to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compared lane 3 to lane 1).</text>
                    <arg n="0">substrate C2Gloi2</arg>
                    <arg n="1">the exon escapement pathway</arg>
                </example>
                <example src="EGRAM" no="327">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, substrate C2Gloi2 will be spliced predominantly after the exon escapement pathway to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compare lane 3 to lane 1).</text>
                    <arg n="0">substrate C2Gloi2</arg>
                    <arg n="1">the exon escapement pathway</arg>
                </example>
                <example src="EGRAM" no="328">
                    <text>When incubated in nuclear extracts or transfects in HeLa cells, substrate C2Gloi2 has been predominantly spliced following the exon escapement pathway to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compared lane 3 to lane 1).</text>
                    <arg n="0">substrate C2Gloi2</arg>
                    <arg n="1">the exon escapement pathway</arg>
                </example>
                <example src="EGRAM" no="329">
                    <text>When incubated in nuclear extracts or transfects in HeLa cells, substrate C2Gloi2 has been spliced following the exon escapement pathway to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compared lane 3 to lane 1).</text>
                    <arg n="0">substrate C2Gloi2</arg>
                    <arg n="1">the exon escapement pathway</arg>
                </example>
                <example src="EGRAM" no="330">
                    <text>When incubated in nuclear extracts or transfects in HeLa cells, substrate C2Gloi2 has the abality to be spliced after the exon escapement pathway at a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">substrate C2Gloi2</arg>
                    <arg n="1">the exon escapement pathway</arg>
                </example>
                <example src="EGRAM" no="331">
                    <text>When incubated in nuclear extracts or transfects in HeLa cells, substrate C2Gloi2 has the abality to be spliced predominantly after the exon escapement pathway at a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">substrate C2Gloi2</arg>
                    <arg n="1">the exon escapement pathway</arg>
                </example>
                <example src="EGRAM" no="332">
                    <text>When incubated in nuclear extracts or transfects in HeLa cells, substrate C2Gloi2 is able to be spliced predominantly by following the exon escapement pathway to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares line 3 with line 1).</text>
                    <arg n="0">substrate C2Gloi2</arg>
                    <arg n="1">the exon escapement pathway</arg>
                </example>
                <example src="EGRAM" no="333">
                    <text>When incubated in nuclear extracts or transfects in HeLa cells, substrate C2Gloi2 may have been spliced predominantly by following the exon escapement pathway to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compare line 3 with line 1).</text>
                    <arg n="0">substrate C2Gloi2</arg>
                    <arg n="1">the exon escapement pathway</arg>
                </example>
                <example src="EGRAM" no="334">
                    <text>When incubated in nuclear or transfected extracts in HeLa cells, C2Gloi2 substrate is able to be spliced predominantly following exonon escaping route to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 and compares line 3 with line 1).</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon escaping route</arg>
                </example>
                <example src="EGRAM" no="335">
                    <text>When incubated into nuclear extracts or spliced into HeLa cells, the A0 substrate (C2Gloi2) is found to be deployed after exon-skipping at a level similar to that obtained with the C2 substrate (undisplayed data and Fig. 2).</text>
                    <arg n="1">exon-skipping</arg>
                </example>
                <example src="EGRAM" no="336">
                    <text>When spliced in nuclear extracts or transfects in HeLa cells, substrate C2Gloi2 may have been impaled by following the exon escapement pathway to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compared lane 3 to lane 1).</text>
                    <arg n="0">substrate C2Gloi2</arg>
                    <arg n="1">the exon escapement pathway</arg>
                </example>
                <example src="EGRAM" no="337">
                    <text>When spliced in nuclear or transfected extracts in HeLa cells, C2Gloi2 substrate was inclined following exonon escaping route to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compared to lane 3 to lane 1).</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon escaping route</arg>
                </example>
                <example src="EGRAM" no="338">
                    <text>When spliced in nuclear or transfected extracts in HeLa cells, C2Gloi2 substrate was predominantly deployed after exonon escaping route to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compared to lane 3 to lane 1).</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon escaping route</arg>
                </example>
                <example src="EGRAM" no="339">
                    <text>a caspasa-2 minigen construction can be made to be alternatively spliced to transcent cells and nuclear extracts.</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                    <arg n="3">transcent cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="340">
                    <text>a caspasa-2 minigen construction can be made to be spliced into transcentric cells and nuclear extracts.</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                    <arg n="3">transcentric cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="341">
                    <text>a caspasa-2 minigen construction can be made to be spliced into transfected cells and nuclear extracts.</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="342">
                    <text>a caspasa-2 minigen construction could be made to alternately spliced into transfected cells and nuclear extracts.</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="343">
                    <text>a caspasa-2 minigen construction could be made to be alternatively spliced to transcent cells and nuclear extracts.</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                    <arg n="3">transcent cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="344">
                    <text>a caspasa-2 minigen construction could be made to be spliced into transcentric cells and nuclear extracts.</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                    <arg n="3">transcentric cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="345">
                    <text>a caspasa-2 minigen construction has been made to be spliced into transcentric cells and nuclear extracts.</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                    <arg n="3">transcentric cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="346">
                    <text>a caspasa-2 minigen construction has the ability to be alternatively spliced in transfected cells and nuclear extracts.</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="347">
                    <text>a caspasa-2 minigen construction has the ability to be spliced into transfected cells and nuclear extracts.</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="348">
                    <text>a caspasa-2 minigen construction is made to be alternatively spliced into transcent cells and nuclear extracts.</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                    <arg n="3">transcent cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="349">
                    <text>a caspasa-2 minigen construction is made to be spliced into transcentric cells and nuclear extracts.</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                    <arg n="3">transcentric cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="350">
                    <text>a caspasa-2 minigen construction may have been made to be alternatively spliced to transcent cells and nuclear extracts.</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                    <arg n="3">transcent cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="351">
                    <text>a caspasa-2 minigen construction may have been made to be spliced into transcent cells and nuclear extracts.</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                    <arg n="3">transcent cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="352">
                    <text>a caspasa-2 minigen construction will be made to be alternatively spliced to transcent cells and nuclear extracts.</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                    <arg n="3">transcent cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="353">
                    <text>a caspasa-2 minigen construction will be made to be spliced into transcentric cells and nuclear extracts.</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                    <arg n="3">transcentric cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="354">
                    <text>a caspasa-2 minigen construction would cause it to be alternatively spliced into transcent cells and nuclear extracts.</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                    <arg n="3">transcent cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="355">
                    <text>a caspasa-2 minigen construction would cause it to be spliced to transcent cells and nuclear extracts.</text>
                    <arg n="0">a caspasa-2</arg>
                    <arg n="3">transcent cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="356">
                    <text>a mNN pre-RNA that contains mutations in SE2, however, is able to spliced the predominant use of the splice nt 3605 3 site.</text>
                    <arg n="0">a mNN pre-RNA that contains mutations in SE2</arg>
                    <arg n="1">the splice nt 3605 3 site</arg>
                </example>
                <example src="EGRAM" no="357">
                    <text>a minigen caspasa-2 building has the ability to be spliced into transfected cells and nuclear extracts.</text>
                    <arg n="0">a minigen caspasa-2 building</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="358">
                    <text>a minigen caspasa-2 building will be done to be spliced in an alternative with transient cells and nuclear extracts.</text>
                    <arg n="0">a minigen caspasa-2 building</arg>
                    <arg n="3">transient cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="359">
                    <text>a minigen caspasa-2 construction can be done to be alternately spliced into transfected cells and nuclear extracts.</text>
                    <arg n="0">a minigen caspasa-2 construction</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="360">
                    <text>a minigen caspasa-2 construction can be done to be spliced into an alternative to transient cells and nuclear extracts.</text>
                    <arg n="0">a minigen caspasa-2 construction</arg>
                    <arg n="3">transient cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="361">
                    <text>a minigen caspasa-2 construction could be done to be spliced into an alternative to transient cells and nuclear extracts.</text>
                    <arg n="0">a minigen caspasa-2 construction</arg>
                    <arg n="3">transient cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="362">
                    <text>a minigen caspasa-2 construction is made to be spliced into transient cells and nuclear extracts.</text>
                    <arg n="0">a minigen caspasa-2 construction</arg>
                    <arg n="3">transient cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="363">
                    <text>a minigen caspasa-2 construction may have been done to be spliced in an alternative with transient cells and nuclear extracts.</text>
                    <arg n="0">a minigen caspasa-2 construction</arg>
                    <arg n="3">transient cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="364">
                    <text>a minigen caspase-2 building may have been done to be spliced into transient cells and nuclear extracts.</text>
                    <arg n="0">a minigen caspase-2 building</arg>
                    <arg n="3">transient cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="365">
                    <text>a minigen caspase-2 construction has been shown to be composed of A3 spliced (transfected cells and nuclear extracts).</text>
                    <arg n="0">a minigen caspase-2 construction</arg>
                </example>
                <example src="EGRAM" no="366">
                    <text>a minigen caspase-2 construction has been spliced to be used alternatively in transfected cells and nuclear extracts.</text>
                    <arg n="0">a minigen caspase-2 construction</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="367">
                    <text>a mutation prior to mRNA containing EE2, however, has been shown to be predominantly divided into A1 (spliced site 3605 3.</text>
                    <arg n="0">a mutation prior to mRNA containing EE2</arg>
                </example>
                <example src="EGRAM" no="368">
                    <text>a pre-RNA containing SE2 mutations, however, can be predominantly spliced with the splice 3 nt 3605 site.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">the splice 3 nt 3605 site</arg>
                </example>
                <example src="EGRAM" no="369">
                    <text>a pre-RNA containing SE2 mutations, however, is likely to be predominantly spliced with nt 3605 slice 3 site.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">nt 3605 slice 3 site</arg>
                </example>
                <example src="EGRAM" no="370">
                    <text>a pre-RNA containing mutations in SE2, however, has the ability to be alternately divided with the 3 nt 3605 spliced site.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the 3 nt 3605</arg>
                </example>
                <example src="EGRAM" no="371">
                    <text>a pre-RNA containing mutations in SE2, however, is predominantly spliced using the splice nt 3605 3 site.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the splice nt 3605 3 site</arg>
                </example>
                <example src="EGRAM" no="372">
                    <text>a pre-RNA containing mutations in SE2, however, was predominantly divided with the 3 nt 3605 spliced site.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the 3 nt 3605</arg>
                </example>
                <example src="EGRAM" no="373">
                    <text>a pre-RNA containing mutations in SE2, however, will predominantly be spliced with nt splicetion site 3605 3.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">nt splicetion site 3605 3</arg>
                </example>
                <example src="EGRAM" no="374">
                    <text>a pre-mRNA containing mutations in SE2 , however, can be spliced predominantly using the nt 3605 3 splice site.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="EGRAM" no="375">
                    <text>a pre-mRNA containing mutations in SE2 , however, has been shown to be alternatively spliced predominantly using the nt 3605 3 splice site.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="EGRAM" no="376">
                    <text>a pre-mRNA containing mutations in SE2 , however, has been spliced predominantly using the nt 3605 3 splice site.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="EGRAM" no="377">
                    <text>a pre-mRNA containing mutations in SE2 , however, has the ability to be alternately spliced predominantly using the nt 3605 3 splice site.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="EGRAM" no="378">
                    <text>a pre-mRNA containing mutations in SE2 , however, is likely to be alternately spliced predominantly using the nt 3605 3 splice site.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="EGRAM" no="379">
                    <text>a pre-mRNA containing mutations in SE2 , however, is observed to be predominantly spliced using the nt 3605 3 splice site.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="EGRAM" no="380">
                    <text>a pre-mRNA containing mutations in SE2 , however, is spliced predominantly using the nt 3605 3 splice site.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="EGRAM" no="381">
                    <text>a pre-mRNA containing mutations in SE2 , however, may have been alternately spliced predominantly using the nt 3605 3 splice site.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="EGRAM" no="382">
                    <text>a pre-mRNA containing mutations in SE2 , however, was spliced predominantly using the nt 3605 3 splice site.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="EGRAM" no="383">
                    <text>a pre-mRNA containing mutations in SE2 , however, will be spliced predominantly using the nt 3605 3 splice site.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="EGRAM" no="384">
                    <text>a pre-mRNA mutation containing EE2, however, EE2 is divided predominantly into A1 (spliced site of 3605 3.</text>
                    <arg n="0">a pre-mRNA mutation containing EE2</arg>
                </example>
                <example src="EGRAM" no="385">
                    <text>a pre-mRNA mutation containing EE2, however, may have been alternately spliced predominantly with nt 3605 slice 3 site.</text>
                    <arg n="0">a pre-mRNA mutation containing EE2</arg>
                    <arg n="1">nt 3605</arg>
                </example>
                <example src="EGRAM" no="386">
                    <text>a pre-mRNA mutation containing EE2, however, was predominantly spliced into the site of 3, 505 and 3 splices.</text>
                    <arg n="0">a pre-mRNA mutation containing EE2</arg>
                    <arg n="1">the site of 3, 505 and 3 splices</arg>
                </example>
                <example src="EGRAM" no="387">
                    <text>exons outside this range of size have been effectively spliced into mature mRNA.</text>
                    <arg n="1">exons outside this range of size</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="EGRAM" no="388">
                    <text>exons outside this range of size have required additional exonic and/or intronic sequences to be effectively spliced into mature mRNA.</text>
                    <arg n="1">exons outside this range of size</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="EGRAM" no="389">
                    <text>exons outside this range of size have required additional exonic and/or intronic sequences to be spliced into mature mRNA.</text>
                    <arg n="1">exons outside this range of size</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="EGRAM" no="390">
                    <text>exons outside this range of size may have required additional exotic and/or intron sequences to be effectively spliced into mature RNA.</text>
                    <arg n="1">exons outside this range of size</arg>
                    <arg n="2">mature RNA</arg>
                </example>
                <example src="EGRAM" no="391">
                    <text>exons outside this range of size may require additional exotic and/or intrusive sequences to be effectively spliced into mature RNA.</text>
                    <arg n="1">exons outside this range of size</arg>
                    <arg n="2">mature RNA</arg>
                </example>
                <example src="EGRAM" no="392">
                    <text>exons outside this range of size required additional exotic and/or intron sequences to be effectively spliced into mature mRNA.</text>
                    <arg n="1">exons outside this range of size</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="EGRAM" no="393">
                    <text>exons outside this range of size requires additional exonic and/or intronic sequences to be effectively spliced into mature mRNA.</text>
                    <arg n="1">exons outside this range of size</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="EGRAM" no="394">
                    <text>exons outside this range of size requires additional exonic and/or intronic sequences to be spliced into mature mRNA.</text>
                    <arg n="1">exons outside this range of size</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="EGRAM" no="395">
                    <text>exons outside this range of size requires additional exotic and/or intron sequences to be spliced into mature mRNA.</text>
                    <arg n="1">exons outside this range of size</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="EGRAM" no="396">
                    <text>exons outside this size range are effectively spliced into mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="EGRAM" no="397">
                    <text>exons outside this size range are spliced into mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="EGRAM" no="398">
                    <text>exons outside this size range has been shown to require additional exonic and/or intrusive sequences to be effectively spliced into mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="EGRAM" no="399">
                    <text>exons outside this size range has been shown to require additional exonic and/or intrusive sequences to be spliced into mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="EGRAM" no="400">
                    <text>exons outside this size range has been shown to require additional exotic and/ or intrusive sequences to be effectively spliced into mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="EGRAM" no="401">
                    <text>exons outside this size range has been shown to require additional exotic and/ or intrusive sequences to be spliced into mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="EGRAM" no="402">
                    <text>exons outside this size range have been spliced into mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="EGRAM" no="403">
                    <text>exons outside this size range have the probability of requiring additional exonic and/or intrusive sequences to be effectively spliced into mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="EGRAM" no="404">
                    <text>exons outside this size range have the probability of requiring additional exonic and/or intrusive sequences to be spliced into mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="EGRAM" no="405">
                    <text>exons outside this size range is able to require additional exotic and/or intron sequences to be spliced into mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="EGRAM" no="406">
                    <text>exons outside this size range is able to require additional exotic and/or intronic sequences to be effectively spliced into mature RNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature RNA</arg>
                </example>
                <example src="EGRAM" no="407">
                    <text>exons outside this size range is able to require additional exotic and/or intronic sequences to be effectively spliced into mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="EGRAM" no="408">
                    <text>exons outside this size range is able to require additional exotic and/or intronic sequences to be spliced into mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="EGRAM" no="409">
                    <text>exons outside this size range is actually spliced into mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="EGRAM" no="410">
                    <text>exons outside this size range is likely to require additional exotic and/or intrusive sequences to be effectively spliced into mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="EGRAM" no="411">
                    <text>exons outside this size range is likely to require additional exotic and/or intrusive sequences to be spliced into mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="EGRAM" no="412">
                    <text>exons outside this size range is spliced into mature RNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature RNA</arg>
                </example>
                <example src="EGRAM" no="413">
                    <text>exons outside this size range may have required additional exotic and/ or intronic sequences to be spliced into mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="EGRAM" no="414">
                    <text>exons outside this size range may have required additional exotic and/ or intrusive sequences to be effectively spliced into mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="EGRAM" no="415">
                    <text>exons outside this size range may have required extra exotic and/or intrusive sequences to be spliced into mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="EGRAM" no="416">
                    <text>exons outside this size range may require additional exotic and/ or intrusive sequences to be effectively spliced into mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="EGRAM" no="417">
                    <text>exons outside this size range may require extra exonic and/or intrusive sequences to be spliced into mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="EGRAM" no="418">
                    <text>exons outside this size range may require extra-exotic and/ or intrusive sequences to be spliced into mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="EGRAM" no="419">
                    <text>exons outside this size range requires additional exotic and/ or intronic sequences to be effectively spliced into mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="EGRAM" no="420">
                    <text>exons outside this size range requires additional exotic and/or intronic sequences to be spliced into mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="EGRAM" no="421">
                    <text>exons outside this size range requires extra exonic and/or intrusive sequences to be effectively spliced into mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="EGRAM" no="422">
                    <text>exons outside this size range requires extra exonic and/or intrusive sequences to be spliced into mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="EGRAM" no="423">
                    <text>exons outside this size range requires extra-exonic and/or intrusive sequences to be effectively spliced into mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="EGRAM" no="424">
                    <text>exons outside this size range was effectively spliced into mature RNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature RNA</arg>
                </example>
                <example src="EGRAM" no="425">
                    <text>exons outside this size range was spliced into mature RNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature RNA</arg>
                </example>
                <example src="EGRAM" no="426">
                    <text>exons outside this size range was spliced into mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="EGRAM" no="427">
                    <text>exons outside this size range were effectively spliced into mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="EGRAM" no="428">
                    <text>exons outside this size range were spliced into mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="EGRAM" no="429">
                    <text>four transcriptional units has also been spliced, which have been observed to be spalmated but contain no obvious open reading framework.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="430">
                    <text>four transcriptional units was also spliced, which was observed to be spalmated, but does not contain an obvious open reading frame.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="431">
                    <text>gen Supt4h can usually be divided from the five exons spliced by chromosome 11.</text>
                    <arg n="0">gen Supt4h</arg>
                    <arg n="1">five exons</arg>
                </example>
                <example src="EGRAM" no="432">
                    <text>gen Supt4h is likely to be spliced from five exons encoded by chromosome 11.</text>
                    <arg n="0">gen Supt4h</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="EGRAM" no="433">
                    <text>minigenous caspase-2 can be made and has been spliced into transfected cells and nuclear extracts.</text>
                    <arg n="0">minigenous caspase-2</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="434">
                    <text>minigenous caspase-2 could be made to be spliced into transfected cells and nuclear extracts.</text>
                    <arg n="0">minigenous caspase-2</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="435">
                    <text>minigenous caspase-2 is able to be made and is spliced into transfected cells and nuclear extracts.</text>
                    <arg n="0">minigenous caspase-2</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="436">
                    <text>minigenous caspase-2 is constituted and can be spliced into transfected cells and nuclear extracts.</text>
                    <arg n="0">minigenous caspase-2</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="437">
                    <text>minigenous caspase-2 is observed to be spliced into transfected cells and nuclear extracts.</text>
                    <arg n="0">minigenous caspase-2</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="438">
                    <text>minigenous caspase-2 was made and it was spliced into transfected cells and nuclear extracts.</text>
                    <arg n="0">minigenous caspase-2</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="439">
                    <text>minigenous caspase-2 will be done and is spliced into transfected cells and nuclear extracts.</text>
                    <arg n="0">minigenous caspase-2</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="440">
                    <text>minigenous caspase-2 would be made and could be spliced into transfected cells and nuclear extracts.</text>
                    <arg n="0">minigenous caspase-2</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="441">
                    <text>pre-mRNAs of all these genes are observed splashed with little or no exon (ref.16; also Fig. 1 C and data not presented) spliced that correct inclusion of exon can be managed by the yeast genes expression machine.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon</arg>
                </example>
                <example src="EGRAM" no="442">
                    <text>pre-mRNAs of all these genes are observed to be spliced with few or no splash exon (ref.16; also Fig.1 C and undisplayed data), suggesting that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no splash exon</arg>
                </example>
                <example src="EGRAM" no="443">
                    <text>pre-mRNAs of all these genes can be spliced with few or no exon-spatch (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatch</arg>
                </example>
                <example src="EGRAM" no="444">
                    <text>pre-mRNAs of all these genes can be spliced with few or no exon-spatch (ref.16; also Fig.1 C and undisplayed data), suggesting that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatch</arg>
                </example>
                <example src="EGRAM" no="445">
                    <text>pre-mRNAs of all these genes can be spliced with little or no exon spacing (ref.16; also Fig. 1 C and data not exposed), suggesting that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spacing</arg>
                </example>
                <example src="EGRAM" no="446">
                    <text>pre-mRNAs of all these genes can be spliced with little or no exon spacing (ref.16; also Fig. 1 C and data not presented) suggesting that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spacing</arg>
                </example>
                <example src="EGRAM" no="447">
                    <text>pre-mRNAs of all these genes has the ability to be spliced with little or no exon spacing (ref.16; also Fig. 1 C and data not exposed), suggesting that the correct inclusion of exon can be managed by the yeast genes expression machine.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spacing</arg>
                </example>
                <example src="EGRAM" no="448">
                    <text>pre-mRNAs of all these genes have been spliced with few or no exon-spatch (ref.16; also Fig.1 C and undisplayed data), suggesting that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatch</arg>
                </example>
                <example src="EGRAM" no="449">
                    <text>pre-mRNAs of all these genes is observed to be deployed with little or no exon splash (ref.16; also Fig. 1 C and data not presented), spliced that correct inclusion of exon can be managed by yeast genes expression machine.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon splash</arg>
                </example>
                <example src="EGRAM" no="450">
                    <text>pre-mRNAs of all these genes is shown to be spliced with little or no exon-spatch (ref.16; also Fig. 1 C and data not presented) suggest that the correct inclusion of exon can be managed by yeast genes expression machine.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon-spatch</arg>
                </example>
                <example src="EGRAM" no="451">
                    <text>pre-mRNAs of all these genes may have been spliced with little or no exon spatter (ref.16; also Fig. 1 C and data not presented), suggesting that the correct inclusion of exon can be managed by the yeast gene expression machine.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spatter</arg>
                </example>
                <example src="EGRAM" no="452">
                    <text>pre-mRNAs of all these genes spliced splashed with few or no splash exon (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no splash exon</arg>
                </example>
                <example src="EGRAM" no="453">
                    <text>pre-mRNAs of all these genes spread with little or no exon spacing (ref.16; also Fig. 1 C and data not presented) spliced that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spacing</arg>
                </example>
                <example src="EGRAM" no="454">
                    <text>pre-mRNAs of all these genes that can be spliced with few or no exon-spatch (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatch</arg>
                </example>
                <example src="EGRAM" no="455">
                    <text>pre-mRNAs of all these genes that can be spliced with little or no exon spacing (ref.16; also Fig. 1 C and data not presented) suggest that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spacing</arg>
                </example>
                <example src="EGRAM" no="456">
                    <text>pre-mRNAs of all these genes that have been spliced with few or no exon-spatch (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatch</arg>
                </example>
                <example src="EGRAM" no="457">
                    <text>pre-mRNAs of all these genes that have the ability to be spliced with few or no exon-spatch (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatch</arg>
                </example>
                <example src="EGRAM" no="458">
                    <text>pre-mRNAs of all these genes that may have been defocused with little or no exon-spatched (ref.16; also Fig. 1 C and data not presented) spliced that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon-spatched</arg>
                </example>
                <example src="EGRAM" no="459">
                    <text>pre-mRNAs of all these genes that may have been spliced with few or no exon-spatched (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatched</arg>
                </example>
                <example src="EGRAM" no="460">
                    <text>pre-mRNAs of all these genes that were spliced with few or no exon-spatch (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatch</arg>
                </example>
                <example src="EGRAM" no="461">
                    <text>pre-mRNAs of all these genes was shown to be spliced with little or no exon spacing (ref. 16; also Fig. 1 C and data not presented) suggesting that the correct inclusion of exon can be treated by yeast genes expression machines.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spacing</arg>
                </example>
                <example src="EGRAM" no="462">
                    <text>pre-mRNAs of all these genes was spliced with little or no exon-spatch (ref. 16; also Fig. 1 C and data not exposed), suggesting that the correct inclusion of exon can be managed by yeast genes expression machines.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon-spatch</arg>
                </example>
                <example src="EGRAM" no="463">
                    <text>pre-mRNAs of all these genes was spliced with little or no exon-spatch (ref.16; also Fig. 1 C and data not exposed), suggesting that the correct inclusion of exon can be managed by the yeast gene expression machine.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon-spatch</arg>
                </example>
                <example src="EGRAM" no="464">
                    <text>pre-mRNAs of all these genes were spliced with few or no exon-spatch (ref.16; also Fig.1 C and undisplayed data), suggesting that the correct inclusion of the exon can be handled by the yeast gene expression machinery.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatch</arg>
                </example>
                <example src="EGRAM" no="465">
                    <text>pre-mRNAs of all these genes were spliced with little or no exon spacing (ref.16; also Fig. 1 C and data not presented) suggesting that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spacing</arg>
                </example>
                <example src="EGRAM" no="466">
                    <text>pre-mRNAs of all these genes which have the ability to be spliced with little or no exon spacing (ref.16; also Fig. 1 C and data not presented) suggest that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spacing</arg>
                </example>
                <example src="EGRAM" no="467">
                    <text>pre-mRNAs of all these genes which were deployed with little or no exon spacer (ref.16; also Fig. 1 C and data not presented) spliced that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spacer</arg>
                </example>
                <example src="EGRAM" no="468">
                    <text>pre-mRNAs of all these genes which were spliced with little or no exon-spatched (ref.16; also Fig. 1 C and data not presented) suggests that the correct inclusion of exon can be managed by the yeast gene expression machine.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon-spatched</arg>
                </example>
                <example src="EGRAM" no="469">
                    <text>pre-mRNAs of all these genes which will be spliced with little or no exon spacing (ref.16; also Fig. 1 C and data not presented) suggest that the correct inclusion of exon can be managed by the yeast genes expression machine.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spacing</arg>
                </example>
                <example src="EGRAM" no="470">
                    <text>pre-mRNAs of all these genes will be cut with little or no exon-spatched (ref.16; also Fig. 1 C and data not spliced), suggesting that the correct inclusion of exon can be managed by the yeast gene expression machine.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon-spatched</arg>
                </example>
                <example src="EGRAM" no="471">
                    <text>the Supt4h gene can usually be spliced from five exons encoded by chromosome 11.</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons</arg>
                </example>
                <example src="EGRAM" no="472">
                    <text>the Supt4h gene can usually be spliced from five exons encoded by chromosome 11.</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="EGRAM" no="473">
                    <text>the Supt4h gene has been spliced to be generally cut from five exons coded by chromosome 11.</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons coded by chromosome 11</arg>
                </example>
                <example src="EGRAM" no="474">
                    <text>the Supt4h gene has the ability to be normally spliced from five exons encoded by chromosome 11.</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="EGRAM" no="475">
                    <text>the Supt4h gene has the ability to be spliced normally from five exons encoded by chromosome 11.</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="EGRAM" no="476">
                    <text>the Supt4h gene has usually been spliced from five exons encoded by chromosome 11.</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="EGRAM" no="477">
                    <text>the Supt4h gene is likely to be spliced normally from five exons encoded by chromosome 11.</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="EGRAM" no="478">
                    <text>the Supt4h gene is likely to be usually spliced from five exons encoded by chromosome 11.</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="EGRAM" no="479">
                    <text>the Supt4h gene is observed to usually be spliced from five exons encoded by chromosome 11.</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="EGRAM" no="480">
                    <text>the Supt4h gene may have been spliced normally from five exons encoded by chromosome 11.</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="EGRAM" no="481">
                    <text>the Supt4h gene may have been typically spliced from five exons encoded by chromosome 11.</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="EGRAM" no="482">
                    <text>the Supt4h gene spliced usually plicated from five exons encoded by chromosome 11.</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="EGRAM" no="483">
                    <text>the Supt4h gene was generally spliced from five exons coded by chromosome 11.</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons coded by chromosome 11</arg>
                </example>
                <example src="EGRAM" no="484">
                    <text>the Supt4h gene was usually spliced from five exons encoded by chromosome 11.</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="EGRAM" no="485">
                    <text>the Supt4h gene will normally be spliced from five exons encoded by chromosome 11.</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="EGRAM" no="486">
                    <text>the Supt4h gene will usually be spliced from five exons coded by chromosome 11.</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons coded by chromosome 11</arg>
                </example>
                <example src="EGRAM" no="487">
                    <text>the Supt4h gene will usually be spliced from five exons encoded by chromosome 11.</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="EGRAM" no="488">
                    <text>the casp-2 minigen (C2) has the ability to be efficiently spliced in vitro, and the relationship between the CASp-2S and casp-2L mRNAs produced was similar to that observed in vivo (Fig.1 C, lane 1).</text>
                    <arg n="0">the casp-2 minigen (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="EGRAM" no="489">
                    <text>the casp-2 minigen (C2) is efficiently spliced in vitro , and the ratio of casp-2S to the produced casp-2L mRNA was similar to the observed in vivo (Fig.1 C, lane 1).</text>
                    <arg n="0">the casp-2 minigen (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="EGRAM" no="490">
                    <text>the casp-2 minigen (C2) is observed to be efficiently spliced in vitro , and the relationship between the produced casp-2S and casp-2L mRNAs is similar to that seen in vivo (Fig.1 C, lane 1).</text>
                    <arg n="0">the casp-2 minigen (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="EGRAM" no="491">
                    <text>the casp-2 minigen (C2) is observed to be efficiently spliced in vitro, and the relationship between the produced casp-2S and casp-2L mRNAs is similar to the observed in vivo (Fig.1 C, lane 1).</text>
                    <arg n="0">the casp-2 minigen (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="EGRAM" no="492">
                    <text>the casp-2 minigen (C2) may have been shown to be efficiently spliced in vitro , and the relationship between the produced casp-2 and casp-2L mRNAs is similar to the observed in vivo (Fig.1 C, lane 1).</text>
                    <arg n="0">the casp-2 minigen (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="EGRAM" no="493">
                    <text>the casp-2 minigen (C2) may have been spliced to be efficiently impaled in vitro, and the relationship between the CASp-2S and casp-2L mRNAs produced was similar to the observed in vivo (Fig.1 C, lane 1).</text>
                    <arg n="0">the casp-2 minigen (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
            </roleset>
        </predicate>
    </framesest>
</PASBIO>
